Patents by Inventor Stephan Vagner

Stephan Vagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROGNOSIS AND PREDICTIVE BIOMARKERS AND BIOLOGICAL APPLICATIONS THEREOF
    Publication number: 20160116480
    Abstract: The present invention relates to a method of evaluating the sensitivity or resistance of a cancer cell to an antitumoral therapeutic treatment. It further relates to the treatment of a cancer with an inhibitor of the eiF4F complex used for the sensitisation of said cancer to an antitumoral therapeutic treatment.
    Type: Application
    Filed: May 13, 2014
    Publication date: April 28, 2016
    Inventors: CAROLINE ROBERT, LISE BOUSSEMART, ISABELLE GIRAULT, STÉPHAN VAGNER
  • Gene expression inducing fusion protein and method for controlling gene expression Induction
    Publication number: 20060134738
    Abstract: The invention relates to a gene expression inducing fusion protein comprising a) a ribonucleic acid linking peptide domain and a post-transcriptional gene expression activator domain and b) a domain enabling cytoplasmic membrane delocalization. The invention also relates to a modulatable permanent external method for controlling gene expression induction by modulating the state of post-translational modulation of the gene expression inducing fusion protein for the expression of said gene.
    Type: Application
    Filed: January 15, 2004
    Publication date: June 22, 2006
    Inventors: Christel Boutonnet, Stephan Vagner, Jean-Charles Faye, Gilles Favre, Abdelhakim Kharrat, Khalil Bouayadi, Laurence Vercaemer